EP2 receptors are a druggable target; blocking them can relieve pain without affecting the healing inflammation, offering a ...

Low-dose aspirin significantly reduced colorectal cancer recurrence in genetically defined patients. A team of researchers led by Karolinska Institutet and Karolinska University Hospital has demonstra ...

Scientists at the NYU Pain Research Center have identified which receptor in prostaglandins-the hormone-like substance ...